← Eichor
Condition: Polyneuropathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Polyneuropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
NA · 1 location(s) · Centro de Reabilitacao do Norte · NCT05461898A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg)
Phase 3 · 129 location(s) · Sanofi · NCT06290141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Phase 2 · 18 location(s) · VA Office of Research and Development · NCT04038502IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies
Phase 2 · 1 location(s) · Endeavor Health · NCT04153422AUTONOMOUS DISORDERS IN CMT
Phase N/A · 1 location(s) · University Medical Center Goettingen · NCT07570446Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
NA · 2 location(s) · IRCCS Eugenio Medea · NCT06742697ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Phase N/A · 40 location(s) · Alnylam Pharmaceuticals · NCT04561518Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Phase N/A · 23 location(s) · argenx · NCT07264426FOot CAre and Exercises ImplementatioN for People With Diabetes in Primary Care
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT05639478A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Bl
Phase 1 · 21 location(s) · AstraZeneca · NCT07064122Two Dose Levels of Privigen in Pediatric CIDP
Phase 4 · 9 location(s) · CSL Behring · NCT03684018Personalized Training for People With Rare Neuromuscular Disorders
NA · 5 location(s) · Oslo University Hospital · NCT06708468Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05010031Exploring the Genetics of Neuropathic Pain
Phase N/A · 5 location(s) · Oslo University Hospital · NCT03862365Thai PainPREDICT Validation Study
NA · 1 location(s) · Chulalongkorn University · NCT07195045Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06229626A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Int
Phase 2 · 19 location(s) · AllRock Bio, Inc. · NCT07175038Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillar
Phase 2 · 13 location(s) · Centre Hospitalier Universitaire Dijon · NCT05577754Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04712812Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Phase N/A · 22 location(s) · Michael Shy · NCT01193075Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2/Phase 3 · 118 location(s) · Janssen Research & Development, LLC · NCT05327114Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3 · 1 location(s) · Amsterdam University Medical Center (UMC), Location Academic · NCT06714838Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06669949Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Phase 4 · 4 location(s) · University of Aarhus · NCT04589299A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · 131 location(s) · Sanofi · NCT06290128A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
Phase N/A · 1 location(s) · University Medical Center Goettingen · NCT07476365To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transth
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06940336Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-la
Phase 1/Phase 2 · 3 location(s) · ENCell · NCT06328712
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.